Kvinapril

Izvor: Wikipedija
Prijeđi na navigaciju Prijeđi na pretragu
Kvinapril
(IUPAC) ime
(3S)-2-[(2S)-2- {[(2S)-1-etoksi-1-okso-4-fenilbutan-2-il]amino}propanoil]-1,2,3,4-tetrahidroizohinolin-3-karboksilna kiselina
Klinički podaci
Robne marke Accupril
AHFS/Drugs.com Monografija
MedlinePlus a692026
Identifikatori
CAS broj 85441-61-8
ATC kod C09AA06
PubChem[1][2] 54892
DrugBank DB00881
ChemSpider[3] 49565
UNII RJ84Y44811 DaY
KEGG[4] D03752 DaY
ChEBI CHEBI:8713 DaY
ChEMBL[5] CHEMBL1592 DaY
Hemijski podaci
Formula C25H30N2O5 
Mol. masa 438,516 g/mol
SMILES eMolekuli & PubHem
Farmakokinetički podaci
Vezivanje za proteine plazme 97%
Poluvreme eliminacije 2 sata
Farmakoinformacioni podaci
Trudnoća ?
Pravni status Prescription only
Način primene Oralno

Kvinapril (Accupril) je inhibitor angiotenzin konvertujućeg enzima (ACE inhibitor) koji se koristi u tretmanu hipertenzije i zatajenja srca.

Farmakologija[uredi | uredi kod]

Kvinapril je prolek. On se konvertuje u aktivni metabolit, kvinaprilat, u jetri.[6]

Reference[uredi | uredi kod]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11 izd.). New York: McGraw-Hill. ISBN 0-07-142280-3. 

Spoljašnje veze[uredi | uredi kod]